Showing results (1381-1390 of 1,536) with videos related to

Sort By:
Pageof 154
Circulation. Cardiovascular Interventions|November 27, 2014
Effect of a real-time radiation monitoring device on operator radiation exposure during cardiac catheterization: the radiation reduction during cardiac catheterization using real-time monitoring studyGeorgios Christopoulos, Aristotelis C Papayannis, Mohammed Alomar, et al.
BMJ Open|March 27, 2025
NeoTRACK trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy - dissection of IO- efficacy in NSCLC by longitudinal tracKing - protocol of a non-randomised, open-label, single-arm, phase II studyRomina M Roesch, Johannes Schnorbach, Laura V Klotz, et al.
British Journal of Pharmacology|October 22, 2017
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: OverviewStephen Ph Alexander, Eamonn Kelly, Neil V Marrion, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series AnalysisMatthew A Spinelli, Katerina A Christopoulos, Carlos V Moreira, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2019
Crystal structure of the M5 muscarinic acetylcholine receptorZiva Vuckovic, Patrick R Gentry, Alice E Berizzi, et al.
British Journal of Cancer|May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study GroupIsabella C Wiest, Lena Dreikhausen, Ralph Keller, et al.
Journal of Medicinal Chemistry|April 23, 2015
Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptorNeil T Burford, Kathryn E Livingston, Meritxell Canals, et al.
Cancer Cell|January 5, 2024
Interferon-stimulated neutrophils as a predictor of immunotherapy responseMadeleine Benguigui, Tim J Cooper, Prajakta Kalkar, et al.
Clinical Lung Cancer|June 29, 2026
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet StudyRajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, et al.
Ebiomedicine|November 8, 2020
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNASteffen Dietz, Petros Christopoulos, Zhao Yuan, et al.
Pageof 154